These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 4741938)

  • 1. Mammary carcinogenesis in the rat by topical application of fluorenylhydroxamic acids.
    Malejka-Giganti D; Gutmann HR; Rydell RE
    Cancer Res; 1973 Oct; 33(10):2489-97. PubMed ID: 4741938
    [No Abstract]   [Full Text] [Related]  

  • 2. Mammary carcinogenesis in the rat by topical application of fluorenylhydroxamic acids and their acetates.
    Malejka-Giganti D; Rydell RE; Gutmann HR
    Cancer Res; 1977 Jan; 37(1):111-7. PubMed ID: 830400
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The carcinogenicity of fluorenylhydroxamic acids and N-acetoxy-N-fluorenylacetamides for the rat as related to the reactivity of the esters toward nucleophiles.
    Yost Y; Gutmann HR; Rydell RE
    Cancer Res; 1975 Feb; 35(2):447-59. PubMed ID: 1109807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radioactivity in rat mammary gland after the administration of 2-acetylaminofluorene-9- 14 C and its N-hydroxy metabolite.
    Janss DH; Irving CC
    J Natl Cancer Inst; 1972 Sep; 49(3):765-71. PubMed ID: 4647496
    [No Abstract]   [Full Text] [Related]  

  • 5. The conversion of noncarcinogenic aromatic amides to carcinogenic arylhydroxamic acids by synthetic N-hydroxylation.
    Gutmann HR; Galitski SB; Foley WA
    Cancer Res; 1967 Aug; 27(8):1443-55. PubMed ID: 6047873
    [No Abstract]   [Full Text] [Related]  

  • 6. Activation of certain N-arylacetamides and N-arylacetohydroxamic acids in relation to mammary gland tumorigenesis in the rat.
    Malejka-Giganti D
    Natl Cancer Inst Monogr; 1981 Dec; (58):69-77. PubMed ID: 6804871
    [TBL] [Abstract][Full Text] [Related]  

  • 7. On the correlation between the hepatocarcinogenicity of the carcinogen, N-2-fluorenylacetamide, and its metabolic activation by the rat.
    Gutmann HR; Malejka-Giganti D; Barry EJ; Rydell RE
    Cancer Res; 1972 Jul; 32(7):1554-61. PubMed ID: 4337834
    [No Abstract]   [Full Text] [Related]  

  • 8. Structure-activity relationships of N-acylarylhydroxylamines in the rat.
    Gutmann HR; Leaf DS; Yost Y; Rydell RE; Chen CC
    Cancer Res; 1970 May; 30(5):1485-98. PubMed ID: 4316729
    [No Abstract]   [Full Text] [Related]  

  • 9. Relationship of metabolic activation of N-hydroxy-N-acylarylamines to biological response in the liver and mammary gland of the female CD rat.
    Shirai T; Fysh JM; Lee MS; Vaught JB; King CM
    Cancer Res; 1981 Nov; 41(11 Pt 1):4346-53. PubMed ID: 6118207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antioxidants and carcinogenesis: butylated hydroxytoluene, but not diphenyl-p-phenylenediamine, inhibits cancer induction by N-2-fluorenylacetamide and by N-hydroxy-N-2-fluorenylacetamide in rats.
    Ulland BM; Weisburger JH; Yamamoto RS; Weisburger EK
    Food Cosmet Toxicol; 1973 Apr; 11(2):199-207. PubMed ID: 4352030
    [No Abstract]   [Full Text] [Related]  

  • 11. Immunocytochemical localization of estrogen receptors in the mammary tissue of female rats: relevance to carcinogenesis.
    Walaszek Z; Sherman U; Adams AK; Hanausek M
    Prog Clin Biol Res; 1994; 387():349-59. PubMed ID: 7972258
    [No Abstract]   [Full Text] [Related]  

  • 12. Aromatic amine carcinogenesis: the importance of N-hydroxylation.
    Clayson DB; Dawson KM; Dean HG
    Xenobiotica; 1971; 1(4):539-42. PubMed ID: 5164806
    [No Abstract]   [Full Text] [Related]  

  • 13. [Long-term histamine administration in inbred C3H female mice and its incidence in the occurrence of mammary adenocarcinomas].
    Scolnik AJ
    Rev Soc Argent Biol; 1971; 47(1):89-96. PubMed ID: 5155410
    [No Abstract]   [Full Text] [Related]  

  • 14. Induction of mammary tumors in aging rats by 7,12-dimethylbenz[a]anthracene: role of DNA synthesis during carcinogenesis.
    Sinha DK; Dao TL
    J Natl Cancer Inst; 1980 Mar; 64(3):519-21. PubMed ID: 6766511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Free amino acid pools of rodent mammary tumors.
    Pine MJ; Kim U; Ip C
    J Natl Cancer Inst; 1982 Sep; 69(3):729-35. PubMed ID: 6810010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The carcinogenicity of the o-methoxy derivatives of N-2-fluorenylacetamide and of related compounds in the rat.
    Gutmann HR; Galitski SB; Foley WA
    Cancer Res; 1968 Feb; 28(2):234-44. PubMed ID: 5641517
    [No Abstract]   [Full Text] [Related]  

  • 17. Histamine and DNA synthesis as age-related and strain-related factors during rat mammary carcinogenesis.
    Schad PJ; Janss DH
    J Natl Cancer Inst; 1980 Nov; 65(5):949-53. PubMed ID: 6776327
    [No Abstract]   [Full Text] [Related]  

  • 18. Distribution of radioactivity and metabolism of formic acid 2-(4-(5-nitro-2-furyl)-2-14C-2-thiazolyl)hydrazide following oral administration to rats and mice.
    Cohen SM; Alter A; Bryan GT
    Cancer Res; 1973 Nov; 33(11):2802-9. PubMed ID: 4748435
    [No Abstract]   [Full Text] [Related]  

  • 19. Chemically-induced breast carcinoma.
    McClain ED
    Proc Inst Med Chic; 1973; 29(9):310. PubMed ID: 4719422
    [No Abstract]   [Full Text] [Related]  

  • 20. Metabolism of the antimammary cancer antiestrogenic agent tamoxifen. I. Cytochrome P-450-catalyzed N-demethylation and 4-hydroxylation.
    Mani C; Gelboin HV; Park SS; Pearce R; Parkinson A; Kupfer D
    Drug Metab Dispos; 1993; 21(4):645-56. PubMed ID: 8104124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.